George H. Conrades

Insider Reports History

Location
500 Technology Square, Fifth Floor, Cambridge, MA
Signature
/s/ Aimee Weast by Aimee Weast, Attorney in Fact for George H. Conrades (POA filed 6/4/19)
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George H. Conrades:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ORACLE CORP Director Common Stock 38.5K $8.21M $213.49 Jun 17, 2025 Direct
Cyclerion Therapeutics, Inc. Director Stock Option (Right to Buy) 20K Jun 14, 2022 Direct
ORACLE CORP Director Restricted Stock Unit 0 May 31, 2025 Direct
ORACLE CORP Director Stock Option 0 Apr 21, 2025 Direct

Insider Reports Filed by George H. Conrades

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ORCL ORACLE CORP Jun 17, 2025 1 -$1.74M 4 Jun 20, 2025 Director
ORCL ORACLE CORP May 31, 2025 3 $0 4 Jun 3, 2025 Director
ORCL ORACLE CORP Apr 21, 2025 2 $979K 4 Apr 23, 2025 Director
ORCL ORACLE CORP May 31, 2024 3 $0 4 Jun 3, 2024 Director
ORCL ORACLE CORP May 3, 2024 3 -$1.48M 4 May 6, 2024 Director
ORCL ORACLE CORP May 1, 2024 3 -$1.85M 4 May 2, 2024 Director
ORCL ORACLE CORP Nov 10, 2023 2 -$525K 4 Nov 13, 2023 Director
ORCL ORACLE CORP May 31, 2023 3 $0 4 Jun 2, 2023 Director
ORCL ORACLE CORP Dec 22, 2022 1 $0 4 Dec 23, 2022 Director
CYCN Cyclerion Therapeutics, Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
ORCL ORACLE CORP May 31, 2022 3 $0 4 Jun 2, 2022 Director
CYCN Cyclerion Therapeutics, Inc. Jun 24, 2021 1 $0 4 Jun 28, 2021 Director
ORCL ORACLE CORP May 31, 2021 3 $0 4 Jun 2, 2021 Director